Connect Biopharma Holdings (CNTB) Enterprise Value (2023 - 2025)
Connect Biopharma Holdings (CNTB) has disclosed Enterprise Value for 3 consecutive years, with -$44.3 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 139.69% to -$44.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$44.3 million through Dec 2025, down 139.69% year-over-year, with the annual reading at -$44.3 million for FY2025, 139.69% down from the prior year.
- Enterprise Value hit -$44.3 million in Q4 2025 for Connect Biopharma Holdings, up from -$54.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$18.5 million in Q4 2024 to a low of -$118.3 million in Q4 2023.
- Historically, Enterprise Value has averaged -$65.3 million across 3 years, with a median of -$63.3 million in 2025.
- Biggest five-year swings in Enterprise Value: surged 84.36% in 2024 and later crashed 139.69% in 2025.
- Year by year, Enterprise Value stood at -$118.3 million in 2023, then soared by 84.36% to -$18.5 million in 2024, then plummeted by 139.69% to -$44.3 million in 2025.
- Business Quant data shows Enterprise Value for CNTB at -$44.3 million in Q4 2025, -$54.7 million in Q3 2025, and -$71.8 million in Q2 2025.